Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
Company Details
- Employees
- 12
- Founded
- -
- Address
- California, Us
- Phone
- +1 956 662 4893
- in****@****elee.co
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- delee.co
- Keywords
- Circulating Tumor Cells, Liquid Biopsy, CTC, Medical Device, Medical Device Oncology, Cancer Diagnostics, Molecular Analysis, CTC Analysis, Cancer Cells, Medical Research, Biotechnology.
- HQ
- California
Delee Corp Questions
Delee Corp's helpline number is +1 956 662 4893
Delee Corp's website is delee.co
Delee Corp's LinkedIn profile is https://www.linkedin.com/company/deleecorp
Delee Corp has
12 employees.
View email and phone details for 12
employees at Delee Corp.
Delee Corp's industry is
Biotechnology Research
Delee Corp's top competitors are
Narval,
Cricere Mx,
Noleus Technologies,
Gliksys,
Medismart.live,
Synergic Bio Solutions,
Grex Ti,
Wmas Nanotechnology Company,
Eva Vr Training,
Seals Ai.
Delee Corp's support email address is info@delee.co
Delee Corp's categories are Biotechnology Research
Delee Corp's founding year is 2017
